Bioprim Lifecare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 10-01-2025
- Paid Up Capital ₹ 0.60 M
as on 10-01-2025
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.09 Cr
as on 10-01-2025
- Revenue 111.86%
(FY 2020)
- Profit 9.09%
(FY 2020)
- Ebitda 259.56%
(FY 2020)
- Net Worth -122.74%
(FY 2020)
- Total Assets 14.88%
(FY 2020)
About Bioprim Lifecare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.60 M.
The company currently has active open charges totaling ₹1.09 Cr.
Nisha Chandran, Divya Nair, Dayanandan Sreedharan, and One other member serve as directors at the Company.
- CIN/LLPIN
U85100KL2017PTC051316
- Company No.
051316
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Dec 2017
- Date of AGM
04 Oct 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thiruvananthapuram, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bioprim Lifecare?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nisha Chandran  | Managing Director | 08-Dec-2017 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Divya Nair | Director | 17-May-2018 | Current |
| Dayanandan Sreedharan | Director | 31-May-2018 | Current |
| Pinki Pillai | Director | 28-May-2020 | Current |
Financial Performance of Bioprim Lifecare.
Bioprim Lifecare Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 111.86% increase. The company also saw a slight improvement in profitability, with a 9.09% increase in profit. The company's net worth observed a substantial decline by a decrease of 122.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bioprim Lifecare?
Unlock access to Bioprim Lifecare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 10 Mar 2020 | ₹0.95 M | Open |
Canara Bank Creation Date: 21 Jan 2020 | ₹0.90 M | Open |
Others Creation Date: 20 Aug 2018 | ₹9.10 M | Open |
How Many Employees Work at Bioprim Lifecare?
Unlock and access historical data on people associated with Bioprim Lifecare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bioprim Lifecare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioprim Lifecare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
